Pharmacogenomics
Pharmacogenomics - Related Videos
01:29
Pharmacogenetics and Pharmacogenomics: Overview
0 Views •
2026
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29
Pharmacogenomics: Identification of New Drug Targets
0 Views •
2026
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
08:18
High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
0 Views •
Cited by 2 •
2019
Measurement of in vitro cholesterol efflux capacity to serum or plasma in macrophage cell models is a promising tool as a biomarker for atherosclerosis. In the present study, we optimize and standardize a fluorescent NBD-cholesterol efflux method and develop a high-throughput analysis using 96-well plates.
09:06
High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture (4C-seq)
0 Views •
Cited by 5 •
2018
The identification of physical interactions between genes and regulatory elements is challenging but has been facilitated by chromosome conformation capture methods. This modification to the 4C-seq protocol mitigates PCR bias by minimizing over-amplification of PCR templates and maximizes the mappability of reads by incorporating an addition restriction enzyme digest step.
06:17
Repeated Blood Collection for Blood Tests in Adult Zebrafish
0 Views •
Cited by 87 •
2015
Repeated blood sampling is necessary and important in animal research. We developed a novel, non-lethal and reliable method for repeated blood collection from adult zebrafish, and applied this method to the study of blood biochemistry, including glucose metabolism.
FAQs
Pharmacogenomics organizes clinically relevant variation by the biological role of the affected gene. Variants in drug-metabolizing enzymes can alter how quickly medication is processed, while transporter variants may influence drug movement. Changes in molecular targets can affect the strength of a drug’s action. Considering these categories helps connect a DNA profile with a specific treatment response.
Pharmacokinetic effects concern what the body does to a medication, including how rapidly it is processed. Pharmacodynamic effects concern what the medication does in the body, including how strongly it acts. Pharmacogenomic interpretation can examine both dimensions, allowing a genetic result to inform whether the main issue is drug handling, drug action, or both.
Inherited differences can change the relationship between a medication and a patient’s biology. A variant affecting processing may alter how the drug is handled, whereas a variant involving a molecular target may change the response at a given level of medication activity. These mechanisms help explain why the same treatment can be effective for one person but less effective or less tolerable for another.
A clinical application begins with a person’s DNA profile and examines variants in genes relevant to the medication. The findings are then related to pharmacokinetic and pharmacodynamic effects, such as processing speed or strength of action. Clinicians can use this interpretation to support medication selection, dose optimization, and assessment of adverse-reaction risk.
When pharmacogenomic findings are integrated with electronic health records and clinical decision tools, genetic information can be connected with medication-related decisions during care. This integration may help clinicians apply relevant results consistently rather than treating them as isolated laboratory information. The intended clinical value is improved treatment safety and effectiveness when medication choices or doses require individualization.
Its clinical relevance extends across medication selection, dose optimization, and adverse-reaction risk assessment. Applying these capabilities across diverse patient populations is important because clinical decision-making should account for variation among individuals rather than assume that one medication strategy will produce the same result for everyone. This approach can support treatment that is more individualized, safe, and effective.